CDSCO approved Durvalumab, cancer treatment of AstraZeneca

CDSCO approved Durvalumab, cancer treatment of AstraZeneca Rajesh Vagh Tue, 03/11/2025 - 16:45 AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation, Directorate General of Health Services, Government of India to import for sale and distribution of Durvalumab solution for infusion 120 mg/2.4 ml an